Adverum Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ADVM and buy or sell other stocks, ETFs, and their options commission-free!About ADVM
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S.
CEOLaurent Fischer, MD
CEOLaurent Fischer, MD
Employees155
Employees155
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded2006
Founded2006
Employees155
Employees155
ADVM Key Statistics
Market cap96.26M
Market cap96.26M
Price-Earnings ratio-0.51
Price-Earnings ratio-0.51
Dividend yield—
Dividend yield—
Average volume169.48K
Average volume169.48K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.75
52 Week high$5.75
52 Week low$1.78
52 Week low$1.78
Stock Snapshot
The current Adverum Biotechnologies(ADVM) stock price is $4.36, with a market capitalization of 96.26M. The stock trades at a price-to-earnings (P/E) ratio of -0.51.
On 2025-12-19, Adverum Biotechnologies(ADVM) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 169.48K.
Over the past 52 weeks, Adverum Biotechnologies(ADVM) stock has traded between a high of $5.75 and a low of $1.78.
Over the past 52 weeks, Adverum Biotechnologies(ADVM) stock has traded between a high of $5.75 and a low of $1.78.
People also own
Based on the portfolios of people who own ADVM. This list is generated using Robinhood data, and it’s not a recommendation.